Eventos
O xoves 27 de febreiro ás 11:00 horas teremos a oportunidade de coñecer o traballo de Lorena García Hevia, do Grupo de Nanomateriais Híbridos (CINBIO, IIS Galicia Sur), que impartirá a charla "Nanomedicine in cancer therapy" dentro do ciclo "Coñece ao #teamCINBIO".
Será de xeito presencial na Sala de seminarios da Torre CACTI.
ABSTRACT:
The use of nanomaterials in cancer research has opened new frontiers in both diagnosis and therapy, offering promising alternatives for more effective and targeted treatments. This talk will explore the potential of carbon nanotubes and solid lipid nanoparticles as innovative nanoplatforms for cancer theranostics. Through a combination of in vitro and in vivo studies, we have investigated the functionalization and application of these nanomaterials to selectively target tumor cells and metastases. Carbon nanotubes have demonstrated significant antitumor properties, interacting with cellular structures to induce cytotoxic effects, while solid lipid nanoparticles provide a biocompatible and versatile vehicle for drug delivery and imaging. Our findings highlight the ability of these nanomaterials to enhance therapeutic efficacy, improve tumor targeting, and offer novel diagnostic opportunities.
BIO:
Lorena García Hevia holds a degree in Biology from the University of Oviedo and a Master’s in Molecular Biology and Biomedicine from the University of Cantabria, where she also completed her Ph.D. in 2016. Her doctoral thesis, which focused on the study of carbon nanotubes as antitumor agents, was recognized with both the Best Doctoral Thesis Award and the Juan María Parés Award.
Following her Ph.D., she completed three postdoctoral research stays. The first was at the Stephenson Cancer Center (USA), where she explored the use of gold nanoparticles in ovarian cancer treatment, employing these nanomaterials as tools to investigate cellular mechanisms. She then joined the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal, where she specialized in the development of smart theranostic nanoparticles for cancer diagnosis (MRI) and treatment (Magnetic hyperthermia). Her third postdoctoral experience took her to Italy, where she joined the Institute of Biorobotics in Pisa, working on a European Horizon 2020 project developing nanocomposites for osteoarthritis treatment and management using ultrasound-mediated therapies.
In 2020, she returned to Spain after securing a "Sara Borrell" contract at the Valdecilla Research Institute. She rejoined the Nanomedicine Group to continue working on the intelligent functionalization of nanomaterials for tumor and metastasis targeting. Two years later, she was awarded a "Juan de la Cierva Incorporación" contract at the University of Cantabria.
Most recently, she obtained a "Ramón y Cajal" contract, allowing her to join the Hybrid Nanomaterials Group at CINBIO. She aims to further advance her scientific career and develop her ongoing research projects in nanomedicine and targeted cancer therapies.
